sciencelife.uchospitals.edu
A Potential New Path to Treating Triple-negative Breast Cancer
UChicago physicians announced the results of a pre-clinical study that could soon lead to phase I clinical trials to treat women with relapsed, metastatic triple-negative breast cancer.